Hørsholm, Denmark, 2 December 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion"), a clinical-stage biotechnology company with a focused portfolio of vaccine candidates targeting infectious diseases and cancer, is proud to announce the approval of its Phase I clinical trial application (CTA) by the Austrian Agency for Health …
(December 2nd, 2024 – Oslo, Norway) Jon Andrè Løkke, Chair of the Board of Directors in Cavendish Hydrogen ASA (“Cavendish Hydrogen”) has purchased 32 000 shares in Cavendish Hydrogen at an average price of NOK 8.89 per share. Ludens AS has today purchased 25 000 shares in Cavendish Hydrogen at …
2 December 2024 15:00 GMT Transparency DirectiveVoting rights and capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 30 November 2024 the issued share capital of AstraZeneca PLC with voting rights is 1,550,317,189 ordinary shares of US$0.25. No …
December 2, 2024 – Aker Solutions ASA (“Aker Solutions”) has today allocated shares to primary insiders participating in the company’s manager share purchase program for 2024. Reference is made to the stock exchange release published earlier today, December 2, 2024, concerning the manager share purchase program and share allocation. Aker Solutions …
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Magnetar Capital Partners LP (b) Owner or controller of interests and short positions disclosed, if …
Reference is made to the stock exchange announcements published by Norse Atlantic ASA (the "Company") on 29 November 2024 regarding the private placement of 19,278,576 new shares in the Company directed towards B T Larsen & Co Ltd at a subscription price of NOK 5.00 per share (the "Subscription Price"), …
Kährs continues to make strides in its commitment to sustainability and customer-centric solutions. A key aspect of Kährs' strategy is to bring production and sourcing closer to its customers and end-consumers, reducing environmental impact and enhancing the availability of its flooring solutions. As part of this initiative, Kährs has strengthened …
Eevia Health ("Eevia" or "The Company") received a MSEK 1,849 / KUSD 169 blanket sales order for the elderberry extract Feno-Sambucus™ 7 ORGANIC from a distributor in the US. The blanket order is from Select Ingredients, a San Diego, California, US distributor. Select Ingredients specializes in organic ingredients and high-quality natural …
Hørsholm, Denmark, 2 December 2024 – ExpreS2ion Biotech Holding AB’s subsidiary ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that filmed company presentations in which CEO Bent Frandsen shared insights into the company’s development strategy and value creation potential are now available on the company’s website. The first presentation was delivered at the Biostock …
Sandvik has completed the previously announced acquisition of Universal Field Robots (UFR), a fast-growing Australia-based provider of autonomous interoperable solutions for the surface mining and underground mining markets. UFR will be reported in Digital Mining Technologies, a division within business area Sandvik Mining and Rock Solutions. UFR has approximately 40 …
